Mar 1, 2017
This week, we kick off with a mixed bag of topics including some notable announcements from Rogers and our thoughts on OPEC’s agreed production cut. In our Your Stock Our Take Segment we review a viewer question on profitable and growing TSX-Venture listed specialty pharma stock BioSyent Inc. (RX:TSX-V). And in our Stars and Dogs of the week we review this year’s largest Canadian IPO, retailer Aritzia Inc. (ATX:TSX) and industrial chemical manufacturer Canexus Corporation (CUS:TSX).

Sign up for the Stock Talk Podcast

Be the first to find out the latest Keystone Financial news, special reports, receive our Stock Talk Podcast, DIY Seminar event info, and Your Stock Our Take videos directly to your inbox for free.